Literature DB >> 1879560

Enhanced cellular uptake of biotinylated antisense oligonucleotide or peptide mediated by avidin, a cationic protein.

W M Pardridge1, R J Boado.   

Abstract

The cellular uptake of a model antisense oligonucleotide complementary to 21 bases of the bovine GLUT-1 glucose transporter mRNA and a model vasopressin peptide that were biotinylated, was markedly stimulated by the presence of avidin, a cationic protein. Conversely, the bacteria homologue of avidin, streptavidin, which is a slightly acidic protein, did not facilitate cellular uptake. The avidin-mediated uptake of biotinylated derivatives was competitively inhibited by another cationic protein, protamine, with a Ki of 5 micrograms/ml; was saturable, temperature- and time-dependent; and was associated with endocytosis. The use of the avidin-biotin system provides a new approach to increasing the cellular uptake of antisense oligonucleotides or peptides.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1879560     DOI: 10.1016/0014-5793(91)80996-g

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  MR contrast probes that trace gene transcripts for cerebral ischemia in live animals.

Authors:  Christina H Liu; Shuning Huang; Jiankun Cui; Young R Kim; Christian T Farrar; Michael A Moskowitz; Bruce R Rosen; Philip K Liu
Journal:  FASEB J       Date:  2007-05-03       Impact factor: 5.191

Review 2.  Antigene, ribozyme and aptamer nucleic acid drugs: progress and prospects.

Authors:  R A Stull; F C Szoka
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

3.  Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery.

Authors:  U Bickel; T Yoshikawa; E M Landaw; K F Faull; W M Pardridge
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

4.  Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides.

Authors:  C Beltinger; H U Saragovi; R M Smith; L LeSauteur; N Shah; L DeDionisio; L Christensen; A Raible; L Jarett; A M Gewirtz
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

5.  Antibody-mediated targeting of siRNA via the human insulin receptor using avidin-biotin technology.

Authors:  Chun-Fang Xia; Ruben J Boado; William M Pardridge
Journal:  Mol Pharm       Date:  2009 May-Jun       Impact factor: 4.939

6.  Drug targeting: synthesis and endocytosis of oligonucleotide-neoglycoprotein conjugates.

Authors:  E Bonfils; C Depierreux; P Midoux; N T Thuong; M Monsigny; A C Roche
Journal:  Nucleic Acids Res       Date:  1992-09-11       Impact factor: 16.971

7.  Oligonucleotides with novel, cationic backbone substituents: aminoethylphosphonates.

Authors:  R Fathi; Q Huang; G Coppola; W Delaney; R Teasdale; A M Krieg; A F Cook
Journal:  Nucleic Acids Res       Date:  1994-12-11       Impact factor: 16.971

Review 8.  CNS delivery via adsorptive transcytosis.

Authors:  Françoise Hervé; Nicolae Ghinea; Jean-Michel Scherrmann
Journal:  AAPS J       Date:  2008-08-26       Impact factor: 4.009

Review 9.  Targeting Transporters for Drug Delivery to the Brain: Can We Do Better?

Authors:  Elena Puris; Gert Fricker; Mikko Gynther
Journal:  Pharm Res       Date:  2022-03-31       Impact factor: 4.580

10.  4F decreases IRF5 expression and activation in hearts of tight skin mice.

Authors:  Hao Xu; John G Krolikowski; Deron W Jones; Zhi-Dong Ge; Paul S Pagel; Kirkwood A Pritchard; Dorothée Weihrauch
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.